Graphite Bio Statistics
Share Statistics
Graphite Bio has 58.24M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 58.24M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.2 and the forward
PE ratio is null.
Graphite Bio's PEG ratio is
-0.05.
| PE Ratio | -1.2 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.81 |
| P/FCF Ratio | -1.48 |
| PEG Ratio | -0.05 |
Financial Ratio HistoryEnterprise Valuation
Graphite Bio has an Enterprise Value (EV) of -36.12M.
| EV / Sales | 0 |
| EV / EBITDA | 0.51 |
| EV / EBIT | 0.4 |
| EV / FCF | 0.36 |
Financial Position
The company has a current ratio of 39.2,
with a Debt / Equity ratio of 0.
| Current Ratio | 39.2 |
| Quick Ratio | 39.2 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is -67.9% and Return on Invested Capital is -39.75%.
| Return on Equity | -67.9% |
| Return on Assets | -66.14% |
| Return on Invested Capital | -39.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-20,775,166.67 |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -85.71% in the
last 52 weeks. The beta is 0.2, so Graphite Bio's
price volatility has been higher than the market average.
| Beta | 0.2 |
| 52-Week Price Change | -85.71% |
| 50-Day Moving Average | 21.26 |
| 200-Day Moving Average | 18.32 |
| Relative Strength Index (RSI) | 49.77 |
| Average Volume (20 Days) | 40,955 |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.41M |
| Operating Income | -73.11M |
| Net Income | -124.65M |
| EBITDA | -70.7M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -15.3 |
Full Income StatementBalance Sheet
The company has 185.86M in cash and 362K in
debt, giving a net cash position of 185.5M.
| Cash & Cash Equivalents | 185.86M |
| Total Debt | 362K |
| Net Cash | 185.5M |
| Retained Earnings | -367.05M |
| Total Assets | 217.32M |
| Working Capital | 197.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -90.01M
and capital expenditures -10.86M, giving a free cash flow of -100.86M.
| Operating Cash Flow | -90.01M |
| Capital Expenditures | -10.86M |
| Free Cash Flow | -100.86M |
| FCF Per Share | -12.38 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
